MBA MBA - HBM Healthcare Investment Advisor
| HBMN Stock | CHF 177.80 0.60 0.34% |
Insider
MBA MBA is Investment Advisor of HBM Healthcare Investments
| Age | 56 |
| Phone | 41 43 888 7171 |
| Web | https://www.hbmhealthcare.com |
HBM Healthcare Management Efficiency
The company has return on total asset (ROA) of (0.1396) % which means that it has lost $0.1396 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2474) %, meaning that it generated substantial loss on money invested by shareholders. HBM Healthcare's management efficiency ratios could be used to measure how well HBM Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Patrick Frost | Swiss Life Holding | 55 | |
| MBA MSc | Tecan Group AG | 50 | |
| Robert Moser | Swiss Life Holding | N/A | |
| WolfHenning Scheider | Partners Group Holding | 61 | |
| Andreas Wilhelm | Tecan Group AG | 54 | |
| V Valentin | VAT Group AG | N/A | |
| Steffen Meister | Partners Group Holding | 52 | |
| Nils Frowein | Swiss Life Holding | 59 | |
| Rene CPA | Partners Group Holding | 52 | |
| Gunter Weisshaar | Tecan Group AG | 63 | |
| Urs Wietlisbach | Partners Group Holding | 62 | |
| Jorg Arnold | Swiss Life Holding | 59 | |
| Rudolf Keller | Swiss Life Holding | N/A | |
| Alfred Gantner | Partners Group Holding | 55 | |
| Ulrich Kanter | Tecan Group AG | 60 | |
| Marcel Erni | Partners Group Holding | 58 | |
| Matthias Aellig | Swiss Life Holding | 52 | |
| Fabian Chiozza | VAT Group AG | 42 | |
| O Mller | VAT Group AG | N/A | |
| G Lutz | VAT Group AG | N/A | |
| Martin Brandle | Tecan Group AG | N/A | |
Management Performance
| Return On Equity | -0.25 | |||
| Return On Asset | -0.14 |
HBM Healthcare Inves Leadership Team
Elected by the shareholders, the HBM Healthcare's board of directors comprises two types of representatives: HBM Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HBM. The board's role is to monitor HBM Healthcare's management team and ensure that shareholders' interests are well served. HBM Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HBM Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Erwin Troxler, Chief Officer | ||
| Benedikt Suter, S Directors | ||
| Andreas Wicki, Chief Officer | ||
| Thomas Thaler, Investment Professional | ||
| MBA MBA, Investment Advisor |
HBM Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HBM Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.14 | |||
| Operating Margin | 1.00 % | |||
| Current Valuation | 2.49 B | |||
| Shares Outstanding | 6.96 M | |||
| Shares Owned By Insiders | 16.89 % | |||
| Shares Owned By Institutions | 4.76 % | |||
| Price To Earning | 10.40 X | |||
| Price To Book | 0.78 X | |||
| Price To Sales | 4.28 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for HBM Stock Analysis
When running HBM Healthcare's price analysis, check to measure HBM Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HBM Healthcare is operating at the current time. Most of HBM Healthcare's value examination focuses on studying past and present price action to predict the probability of HBM Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HBM Healthcare's price. Additionally, you may evaluate how the addition of HBM Healthcare to your portfolios can decrease your overall portfolio volatility.